Please Wait.....
Report
OTC Drugs, Medical Devices and Diagnostics: Global Markets
Market Research Report I 2025-01-03 I 139 Pages I BCC Research
Description
Report Scope:
The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics based on products and applications. Based on product, OTC drugs, medical devices, and diagnostics are categorized into OTC drugs (pharmaceutical drugs and vitamin and mineral supplements) and OTC devices and diagnostics (monitoring devices, therapeutic devices, and diagnostic devices and kits). Based on application, the report is segmented into respiratory disorders, orthopedic diseases, gastrointestinal disorders, diabetes, obesity, cardiovascular diseases, ENT disorders, skin disorders, sleep disorders, and other disorders.
Report Includes:
- 36 data tables and 69 additional tables
- An up-to-date overview of the global markets for OTC drugs, medical devices and diagnostics
- Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by product type, application, and geographic region
- Discussion of how the rise in the number of diseases are creating a constant need for OTC drugs, medical devices, and diagnostics for disease management
- A look at the key market drivers and restraints that will shape the market for OTC drugs, medical devices, and diagnostics over the next five years (2024-2029)
- A discussion on ESG challenges and practices in the industry
- Review of patents issued for OTC drugs, medical devices, and diagnostics
- Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews
- Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
- Company profiles of major players within the industry, including Haleon Group of Co., Kenvue, Sanofi, and Bayer AG
Executive Summary
Summary:
The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Introduction
Types of OTC Products
Pharmaceutical OTC Drugs
Vitamin and Mineral Supplements
OTC Medical Devices and Diagnostics
Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics
Cost Savings Analysis
PESTLE Analysis
Porter's Five Forces Analysis
Bargaining Power of Buyers: High
Bargaining Power of Suppliers: Moderate
Potential of New Entrants to the Market: Moderate
Competition in the Industry: High
Threat of Substitutes: Moderate to High
Regulatory Landscape
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Growing Prevalence of Chronic Diseases and Expanding Geriatric Populations
Increasing Health Awareness
Growing Online Sales Channels and Telehealth Platforms
Market Restraints
Presence of Alternative Methods
Market Opportunities
Emerging Economies
Market Challenges
Misuse and Interactions of OTC Drugs and Medical Devices
Data Privacy and Security Concerns
Chapter 4 Emerging Technologies and Developments
Emerging Technologies
Advanced Drug Delivery
Advanced Wearable Sensors
Artificial Intelligence
Clinical Trials Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product
OTC Drugs
Pharmaceutical Drugs
Vitamin and Mineral Supplements
OTC Devices and Diagnostics
Monitoring Devices
Therapeutic Devices
Diagnostic Devices and Kits
Market Breakdown by Application
Respiratory Disorders
Gastrointestinal Disorders
Orthopedic Diseases
Cardiovascular Diseases
Diabetes
Skin Disorders
Obesity
ENT Disorders
Sleep Disorders
Other Disorders
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Market Analysis
Strategic Analysis
Chapter 7 Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective
Introduction to ESG
Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective
Key ESG Issues
OTC Drug, Medical Device, and Diagnostics ESG Performance Analysis
Concluding Remarks from BCC
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
BAYER AG
DSM-FIRMENICH
HALEON GROUP OF CO.
KENVUE
KONINKLIJKE PHILIPS N.V.
MASIMO
NESTLE
PROCTER & GAMBLE
SANOFI
List of Tables
Summary Table : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Product, Through 2029
Table 1 : Difference between Prescription v/s OTC Pharmaceutical Drugs
Table 2 : Top OTC Pharmaceutical Drugs in Major Categories
Table 3 : Top Vitamin and Mineral Supplements in Major Categories
Table 4 : Top OTC Medical Devices and Diagnostics in Major Categories
Table 5 : FDA Medical Device Classification
Table 6 : EU MDR Medical Device Classification
Table 7 : Asia-Pacific: Regulatory Landscape
Table 8 : RoW: Regulatory Landscape
Table 9 : Global: Leading causes of Disease Burden, 2022 v/s 2050
Table 10 : U.S.: Sufferers Using Only OTC Products, 2019
Table 11 : Comparison of FDA-Cleared Health Monitoring Watches
Table 12 : OTC Drugs: Adverse Effects
Table 13 : OTC Drug Interaction with Disorders
Table 14 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Type of Study, October 2024
Table 15 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Status, October 2024
Table 16 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Phase, October 2024
Table 17 : OTC Drugs, Medical Devices and Diagnostics Inclusion, by Product
Table 18 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product, Through 2029
Table 19 : Global Market for OTC Drugs, by Region, Through 2029
Table 20 : Global Market for OTC Drugs, by Type, Through 2029
Table 21 : Most Common OTC Cough, Cold and Respiratory Drugs
Table 22 : Most Common OTC Analgesic/Antipyretic
Table 23 : Most Common OTC Gastrointestinal Drugs
Table 24 : Most Common OTC Dermatological Drugs
Table 25 : Key Marketed OTC Pharmaceutical Drugs, by Company
Table 26 : Global Market for Pharmaceutical Drugs, by Region, Through 2029
Table 27 : Key Marketed Vitamin and Mineral Supplements, by Company
Table 28 : Global Market for Vitamin and Mineral Supplements, by Region, Through 2029
Table 29 : Global Market for OTC Devices and Diagnostics, by Region, Through 2029
Table 30 : Global Market for OTC Devices and Diagnostics, by Type, Through 2029
Table 31 : OTC Cardiac Monitoring Devices, by Company
Table 32 : OTC Blood Pressure Monitoring Devices, by Company
Table 33 : OTC Pulse Oximeter, by Company
Table 34 : OTC Glucose Monitoring Devices, by Company
Table 35 : OTC Sleep Monitoring Devices, by Company
Table 36 : Fetal Monitoring Devices, by Company
Table 37 : Global Market for Monitoring Devices, by Region, Through 2029
Table 38 : Pain Management Devices, by Company
Table 39 : Rehabilitation Devices, by Company
Table 40 : Other OTC Devices, by Company
Table 41 : Global Market for Therapeutic Devices, by Region, Through 2029
Table 42 : Diagnostic Devices and Kits, by Company
Table 43 : Global Market for Diagnostic Devices and Kits, by Region, Through 2029
Table 44 : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Application, Through 2029
Table 45 : Global Market for Respiratory Disorders, by Region, Through 2029
Table 46 : Gastrointestinal Disorders: OTC Drug Management
Table 47 : Global Market for Gastrointestinal Disorders, by Region, Through 2029
Table 48 : Global Market for Orthopedic Diseases, by Region, Through 2029
Table 49 : Global Market for Cardiovascular Diseases, by Region, Through 2029
Table 50 : Worldwide Diabetes Estimates (20-79 Years), by Region, 2021-2045
Table 51 : Global Market for Diabetes, by Region, Through 2029
Table 52 : Global Market for Skin Disorders, by Region, Through 2029
Table 53 : Global Market for Obesity, by Region, Through 2029
Table 54 : Global Market for ENT Disorders, by Region, Through 2029
Table 55 : Global Market for Sleep Disorders, by Region, Through 2029
Table 56 : Global Market for Other Disorders, by Region, Through 2029
Table 57 : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Region, Through 2029
Table 58 : North American Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 59 : European Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 60 : Asia-Pacific Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 61 : OTC Pharmaceutical Drugs: Market Player Share Analysis, 2023
Table 62 : OTC Drugs, Medical Devices, and Diagnostics: Recent Strategic Developments, 2022-2024
Table 63 : ESG Rankings for OTC Drug, Medical Device, and Diagnostics Companies, 2024*
Table 64 : ESG: Environmental Overview
Table 65 : ESG: Social Overview
Table 66 : ESG: Governance Overview
Table 67 : Report Specific Information Sources
Table 68 : Abbreviations Used in OTC Drugs, Medical Devices, and Diagnostics Market
Table 69 : Abbott: Company Snapshot
Table 70 : Abbott: Financial Performance, FY 2022 and 2023
Table 71 : Abbott: Product Portfolio
Table 72 : Abbott: News/Key Developments, 2021-2024
Table 73 : Bayer AG: Company Snapshot
Table 74 : Bayer AG: Financial Performance, FY 2022 and 2023
Table 75 : Bayer AG: Product Portfolio
Table 76 : DSM-Firmenich: Company Snapshot
Table 77 : DSM-Firmenich: Financial Performance, FY 2022 and 2023
Table 78 : DSM-Firmenich: Product Portfolio
Table 79 : DSM-Firmenich: News/Key Developments, 2023
Table 80 : Haleon Group of Co.: Company Snapshot
Table 81 : Haleon Group of Co.: Financial Performance, FY 2022 and 2023
Table 82 : Haleon Group of Co.: Product Portfolio
Table 83 : Haleon Group of Co.: News/Key Developments, 2023 and 2024
Table 84 : Kenvue: Company Snapshot
Table 85 : Kenvue: Financial Performance, FY 2022 and 2023
Table 86 : Kenvue: Product Portfolio
Table 87 : Koninklijke Philips N.V.: Company Snapshot
Table 88 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 89 : Koninklijke Philips N.V.: Product Portfolio
Table 90 : Masimo: Company Snapshot
Table 91 : Masimo: Financial Performance, FY 2022 and 2023
Table 92 : Masimo: Product Portfolio
Table 93 : Masimo: News/Key Developments, 2024
Table 94 : Nestle: Company Snapshot
Table 95 : Nestle: Financial Performance, FY 2022 and 2023
Table 96 : Nestle: Product Portfolio
Table 97 : Nestle: News/Key Developments, 2024
Table 98 : Procter & Gamble: Company Snapshot
Table 99 : Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 100 : Procter & Gamble: Product Portfolio
Table 101 : Sanofi: Company Snapshot
Table 102 : Sanofi: Financial Performance, FY 2022 and 2023
Table 103 : Sanofi: Product Portfolio
Table 104 : Sanofi: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Product, 2021-2029
Figure 1 : Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics
Figure 2 : OTC Drugs, Medical Devices, and Diagnostics: PESTLE Analysis
Figure 3 : Market Dynamics of OTC Drugs, Medical Devices, and Diagnostics
Figure 4 : Global Population Share Above 65 Years, 2019-2023
Figure 5 : Security Risk of Wearable
Figure 6 : Emerging Trends/Technologies in the OTC Drugs, Medical Device and Diagnostics Market
Figure 7 : Global Market Shares for OTC Drugs, Medical Devices and Diagnostics, by Product, 2023
Figure 8 : Global Market Shares for OTC Drugs, by Type, 2023
Figure 9 : Global Market Shares for OTC Devices and Diagnostics, by Type, 2023
Figure 10 : Global Market Shares for OTC Drugs, Medical Devices, and Diagnostics, by Application, 2023
Figure 11 : Percentage of Population Aged 65 Years and Above, by Region, 2050
Figure 12 : Worldwide Diabetes Estimates (20-79 Years), by Region, 2021, 2030 and 2045
Figure 13 : Global Market Shares for OTC Drugs, Medical Devices, and Diagnostics, by Region, 2023
Figure 14 : North American Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 15 : U.S. Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 16 : Canadian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 17 : European Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 18 : German Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 19 : U.K. Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 20 : French Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 21 : Italian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 22 : Rest of European Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 23 : Asia-Pacific Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 24 : Chinese Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 25 : Indian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 26 : Japanese Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 27 : Rest of Asia-Pacific Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 28 : Rest of the World Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 29 : Major Vitamin and Mineral Supplements Players
Figure 30 : Major OTC Medical Device Players
Figure 31 : ESG Pillars
Figure 32 : Advantages of ESG for Companies
Figure 33 : Key ESG Issues in the OTC Drug, Medical Device, and Diagnostics Industry
Figure 34 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 35 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 36 : Bayer AG: Revenue Shares, by Business Unit, FY 2023
Figure 37 : Bayer AG: Revenue Shares, by Country/Region, FY 2023
Figure 38 : DSM-Firmenich: Revenue Shares, by Business Unit, FY 2023
Figure 39 : DSM-Firmenich: Revenue Shares, by Country/Region, FY 2023
Figure 40 : Haleon Group of Co.: Revenue Shares, by Business Unit, FY 2023
Figure 41 : Haleon Group of Co.: Revenue Shares, by Country/Region, FY 2023
Figure 42 : Kenvue: Revenue Shares, by Business Unit, FY 2023
Figure 43 : Kenvue: Revenue Shares, by Country/Region, FY 2023
Figure 44 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023
Figure 45 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023
Figure 46 : Masimo: Revenue Shares, by Business Unit, FY 2023
Figure 47 : Masimo: Revenue Shares, by Country/Region, FY 2023
Figure 48 : Nestle: Revenue Shares, by Business Unit, FY 2023
Figure 49 : Nestle: Revenue Shares, by Country/Region, FY 2023
Figure 50 : Procter & Gamble: Revenue Shares, by Business Unit, FY 2023
Figure 51 : Procter & Gamble: Revenue Shares, by Country/Region, FY 2023
Figure 52 : Sanofi: Revenue Shares, by Business Unit, FY 2023
Figure 53 : Sanofi: Revenue Shares, by Country/ Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security